ResMed Statement on COVID-19
March 23 2020 - 4:15PM
Business Wire
ResMed (NYSE: RMD) (ASX: RMD) has released the following
statement from CEO Mick Farrell regarding the evolving coronavirus
disease (COVID-19) outbreak:
“As a global leader in respiratory medicine, ResMed stands with
the world in the face of the latest coronavirus disease COVID-19
and is ready to help mitigate its effects, helping people breathe
while their immune system fights this virus. More than 7,500
ResMedians are working in over 140 countries for this purpose. We
are working with governments, health authorities, hospitals,
physicians, and patients worldwide to assess their needs, and to
deliver the ventilation therapy that is essential to treat the
respiratory complications of COVID-19. Our primary focus is to
maximize the availability of ResMed ventilators and other
respiratory support devices for the patients that need them
most.
“As global leaders in digital health, we’re proud that many of
our ventilators and bilevel respiratory devices are
cloud-connected, enabling physicians and respiratory specialists to
remotely monitor their patients. There could not be a clearer case
for the use of digital health and remote monitoring of patients
than this current crisis with a virus that is so contagious
stemming from direct human contact.
“I’m grateful to our global team for working through today’s
challenges to help treat an increasing number of COVID-19 patients.
I’d like to call out first-responder ResMedians in China’s Hubei
province, the epicenter of the coronavirus outbreak, in particular
one ResMed hero who, since early January, has donned a positive
pressure hazmat suit, and helped set up thousands of people on
ResMed ventilators and ResMed masks. There are also 100-plus
ResMedians from Malaysia who in mid-March volunteered to keep
working in our Singapore manufacturing plant when Malaysia closed
its borders, relocating to live near our plant in Singapore,
spending weeks away from their families, so they can continue to
produce as many lifesaving ventilators and ventilation masks as
possible.
“ResMed is taking every measure possible worldwide to maximize
the production of ventilators, masks, and other respiratory
devices. We are looking to double or triple the output of
ventilators, and scale up ventilation mask production more than
tenfold. Our team is also taking precautions such as a
work-from-home policy for all employees who can do that, social
distancing, and ensuring world-class quality, safety, good
manufacturing practices, and top-level hygiene procedures at our
manufacturing, service, and distribution centers to help ensure
quality, safety, and business continuity.
“I urge all of us to do our part to help reduce the spread of
the coronavirus, whether that is self-quarantining, working from
home, sheltering in place, or just staying healthy for our
families, particularly the elderly and those with compromised
immune systems.
“Let me close with this: I would like to personally thank the
front-line clinical heroes – many thousands of respiratory
therapists, respiratory nurses, pulmonary and critical care
medicine physicians, as well as hospital and clinical staff who set
up our ventilators and masks for patients in need and deliver the
lifesaving gift of breath... You are the superheroes of this
COVID-19 crisis, and we salute you!”
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions
that treat and keep people out of the hospital, empowering them to
live healthier, higher-quality lives. Our cloud-connected medical
devices transform care for people with sleep apnea, COPD, and other
chronic diseases. Our comprehensive out-of-hospital software
platforms support the professionals and caregivers who help people
stay healthy in the home or care setting of their choice. By
enabling better care, we improve quality of life, reduce the impact
of chronic disease, and lower costs for consumers and healthcare
systems in more than 140 countries. To learn more, visit ResMed.com
and follow @ResMed.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200323005663/en/
For media Jayme Rubenstein +1 858.836.6798
news@resmed.com
For investors Amy Wakeham +1 858.836.5000
investorrelations@resmed.com
Resmed (ASX:RMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Resmed (ASX:RMD)
Historical Stock Chart
From Sep 2023 to Sep 2024